US Stock MarketDetailed Quotes

Hemab Therapeutics Holdings (COAG)

Watchlist
  • 26.940
  • +1.390+5.44%
Close Jun 11 16:00 ET
  • 26.940
  • 0.0000.00%
Post 16:10 ET
1.26BMarket Cap-16.70P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hemab Therapeutics Holdings (COAG) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-65.61%-21.58M
-34.84%-61.48M
-13.03M
-45.59M
Net income from continuing operations
-48.22%-22.69M
-31.22%-63.91M
---15.31M
---48.71M
Depreciation and amortization
-2.67%73K
22.58%304K
--75K
--248K
Other non cash items
-70.63%153K
-158.44%-464K
--521K
--794K
Change In working capital
-73.70%375K
-6.36%1.36M
--1.43M
--1.45M
-Change in prepaid assets
1,893.85%1.17M
-526.74%-2.16M
---65K
---344K
-Change in payables and accrued expense
-84.39%382K
80.01%4.09M
--2.45M
--2.27M
-Change in other current assets
-27.00%-1.02M
-511.11%-55K
---800K
---9K
-Change in other current liabilities
-0.64%-157K
-10.83%-522K
---156K
---471K
Cash from discontinued investing activities
Operating cash flow
-65.61%-21.58M
-34.84%-61.48M
---13.03M
---45.59M
Investing cash flow
Cash flow from continuing investing activities
-164.38%-15.85M
-231.63%-81.48M
-5.99M
61.9M
Net PPE purchase and sale
-600.00%-112K
94.33%-16K
---16K
---282K
Net investment purchase and sale
-163.22%-15.74M
-231.01%-81.47M
---5.98M
--62.19M
Cash from discontinued investing activities
Investing cash flow
-164.38%-15.85M
-231.63%-81.48M
---5.99M
--61.9M
Financing cash flow
Cash flow from continuing financing activities
-1,486.21%-460K
156,401.00%156.3M
-29K
-100K
Net issuance payments of debt
-58.62%-46K
-20.00%-120K
---29K
---100K
Net preferred stock issuance
----
--156.42M
----
--0
Net other financing activities
---414K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-1,486.21%-460K
156,401.00%156.3M
---29K
---100K
Net cash flow
Beginning cash position
18.23%87.97M
27.86%74.41M
--74.41M
--58.2M
Current changes in cash
-98.84%-37.89M
-17.69%13.34M
---19.06M
--16.21M
Effect of exchange rate changes
---223K
--223K
--0
--0
End cash Position
-9.92%49.86M
18.23%87.97M
--55.35M
--74.41M
Free cash flow
-66.27%-21.7M
-34.04%-61.49M
---13.05M
---45.87M
Currency Unit
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -65.61%-21.58M-34.84%-61.48M-13.03M-45.59M
Net income from continuing operations -48.22%-22.69M-31.22%-63.91M---15.31M---48.71M
Depreciation and amortization -2.67%73K22.58%304K--75K--248K
Other non cash items -70.63%153K-158.44%-464K--521K--794K
Change In working capital -73.70%375K-6.36%1.36M--1.43M--1.45M
-Change in prepaid assets 1,893.85%1.17M-526.74%-2.16M---65K---344K
-Change in payables and accrued expense -84.39%382K80.01%4.09M--2.45M--2.27M
-Change in other current assets -27.00%-1.02M-511.11%-55K---800K---9K
-Change in other current liabilities -0.64%-157K-10.83%-522K---156K---471K
Cash from discontinued investing activities
Operating cash flow -65.61%-21.58M-34.84%-61.48M---13.03M---45.59M
Investing cash flow
Cash flow from continuing investing activities -164.38%-15.85M-231.63%-81.48M-5.99M61.9M
Net PPE purchase and sale -600.00%-112K94.33%-16K---16K---282K
Net investment purchase and sale -163.22%-15.74M-231.01%-81.47M---5.98M--62.19M
Cash from discontinued investing activities
Investing cash flow -164.38%-15.85M-231.63%-81.48M---5.99M--61.9M
Financing cash flow
Cash flow from continuing financing activities -1,486.21%-460K156,401.00%156.3M-29K-100K
Net issuance payments of debt -58.62%-46K-20.00%-120K---29K---100K
Net preferred stock issuance ------156.42M------0
Net other financing activities ---414K------------
Cash from discontinued financing activities
Financing cash flow -1,486.21%-460K156,401.00%156.3M---29K---100K
Net cash flow
Beginning cash position 18.23%87.97M27.86%74.41M--74.41M--58.2M
Current changes in cash -98.84%-37.89M-17.69%13.34M---19.06M--16.21M
Effect of exchange rate changes ---223K--223K--0--0
End cash Position -9.92%49.86M18.23%87.97M--55.35M--74.41M
Free cash flow -66.27%-21.7M-34.04%-61.49M---13.05M---45.87M
Currency Unit USDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.48%
Sample Name
Sample Code
 +1.20%
Sample Name
Sample Code
 -2.64%
4
ProShares Ultra Energy
DIG
-2.80%
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-2.93%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.08%
Sample Name
Sample Code
 +3.63%
Sample Name
Sample Code
 +3.45%
4
Amer Sports
AS
+3.22%
5
NetEase
NTES
+2.95%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran conflict shows signs of easing. On the 11th, Eastern Time, Trump revealed that the United States and Iran are expected to reac Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -